Uphealth Stock Fundamentals

UPHDelisted Stock  USD 1.61  0.09  5.29%   
Uphealth fundamentals help investors to digest information that contributes to Uphealth's financial success or failures. It also enables traders to predict the movement of Uphealth Stock. The fundamental analysis module provides a way to measure Uphealth's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Uphealth stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Uphealth Company Return On Equity Analysis

Uphealth's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Uphealth Return On Equity

    
  -0.75  
Most of Uphealth's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Uphealth is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Uphealth has a Return On Equity of -0.7522. This is 96.86% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is 142.65% higher than that of the company.

Uphealth Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Uphealth's current stock value. Our valuation model uses many indicators to compare Uphealth value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Uphealth competition to find correlations between indicators driving Uphealth's intrinsic value. More Info.
Uphealth is rated third in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Uphealth's earnings, one of the primary drivers of an investment's value.

Uphealth Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Uphealth's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Uphealth could also be used in its relative valuation, which is a method of valuing Uphealth by comparing valuation metrics of similar companies.
Uphealth is currently under evaluation in return on equity category among its peers.

Uphealth Fundamentals

About Uphealth Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Uphealth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Uphealth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Uphealth based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
UpHealth, Inc. operates as a digital health services company. The companys solutions include Syntranet Core Platform, an integrated care management platform Cloudbreak, a provider of unified telemedicine solutions and digital health tools HelloLyf from Glocal, a platform that delivers primary care and specialty consultations and MedQuest Pharmacy, a full-service retail and compounding licensed pharmacy that dispenses prescribed medications shipped directly to patients. Uphealth operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 882 people.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in Uphealth Stock

If you are still planning to invest in Uphealth check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Uphealth's history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets